Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/23/2014 | US20140314863 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
10/23/2014 | US20140314862 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
10/23/2014 | US20140314861 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
10/23/2014 | US20140314860 Enteric coated multiparticulate composition with proteinaceous subcoat |
10/23/2014 | US20140314859 Agent for evading immune response |
10/23/2014 | US20140314856 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
10/23/2014 | US20140314855 Coated mesoporous nanoparticles |
10/23/2014 | US20140314853 Microspheres for controlled- or sustained-release delivery of therapeutics |
10/23/2014 | US20140314852 Nanoparticulate systems prepared from sorbitan esters |
10/23/2014 | US20140314848 Pharmaceutical compositions of antihypertensives |
10/23/2014 | US20140314847 Controlled release pharmaceutical compositions with improved bioavailabililty |
10/23/2014 | US20140314846 Multiple unit pharmaceutical formulation |
10/23/2014 | US20140314845 Spherical erythritol granules for direct compression and process of producing same, process of producing tablets by tableting the erythritol granules with a pharmaceutically effective ingredient or nutritional ingredient, and tablets or ordinary candy tablets obtained thereby |
10/23/2014 | US20140314844 Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability |
10/23/2014 | US20140314842 Carbidopa/lipodopa gastroretentive drug delivery |
10/23/2014 | US20140314839 Controlled-release peptide compositions and uses thereof |
10/23/2014 | US20140314835 Sustained release of antiinfectives |
10/23/2014 | US20140314833 Methods and compositions involving mirna and mirna inhibitor molecules |
10/23/2014 | US20140314830 Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec) |
10/23/2014 | US20140314821 Medical implants with reservoir(s) and materials preparable from same |
10/23/2014 | US20140314815 Adhesive solid gel-forming formulations for dermal drug delivery |
10/23/2014 | US20140314781 Formulation of human antibodies for treating tnf-alpha associated disorders |
10/23/2014 | US20140314684 Medicinal aerosol formulations |
10/23/2014 | US20140314683 Mineral, Nutritional, Cosmetic, Pharmaceutical, And Agricultural Compositions And Methods For Producing The Same |
10/23/2014 | US20140314680 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
10/23/2014 | US20140314672 Nanoparticle therapeutic agents, their formulations, and methods of their use |
10/23/2014 | US20140314664 Hydrophobic Molecule-Induced Branched Polymer Aggregates And Their Use |
10/21/2014 | US8865879 Chitosan beads and filler comprising such beads |
10/21/2014 | US8865793 Water-based ink-jet recording ink |
10/21/2014 | US8865778 Extended release excipient and its use |
10/21/2014 | US8865776 Use of low molecular weight amino alcohols in ophthalmic compositions |
10/21/2014 | US8865774 Methods of treating infectious diseases |
10/21/2014 | US8865765 Method for treating eczema |
10/21/2014 | US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
10/21/2014 | US8865743 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
10/21/2014 | US8865710 Methods of treating proliferative diseases |
10/21/2014 | US8865695 Steroidal compositions |
10/21/2014 | US8865692 Compositions for the treatment of gastrointestinal inflammation |
10/21/2014 | US8865691 Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
10/21/2014 | US8865685 Esters for treatment of ocular inflammatory conditions |
10/21/2014 | US8865681 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
10/21/2014 | US8865659 Compositions for prevention or treatment of Hepatitis C virus containing ginsenoside Rg3 as an active ingredient |
10/21/2014 | US8865654 Eye drops |
10/21/2014 | US8865647 Pharmaceutical solution of non covalently bound albumin and acylated insulin |
10/21/2014 | US8865646 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging |
10/21/2014 | US8865644 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof |
10/21/2014 | US8865250 Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
10/21/2014 | US8865247 Needle coating formulation having lubricity and durability |
10/21/2014 | US8865240 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
10/21/2014 | US8865235 Microbicidal and antiparasitic compositions |
10/21/2014 | US8865233 Compositions and methods for treating Demodex infestations |
10/21/2014 | US8865232 Method for treating ocular Demodex |
10/21/2014 | US8865228 Stable vitamin C compositions |
10/21/2014 | US8865227 Metal carbonate particles and methods of making thereof |
10/21/2014 | US8865223 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
10/21/2014 | US8865222 Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof |
10/21/2014 | US8865221 Swellable and degradable microspheres |
10/21/2014 | US8865220 Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres |
10/21/2014 | US8865219 Orodispersible tablets of bitter active principles |
10/21/2014 | US8865218 Microencapsulation process of sertoli cells, microcapsules obtained and use for treatment of type I diabetes mellitus |
10/21/2014 | US8865217 Oral preparation comprising pioglitazone |
10/21/2014 | US8865216 Surface-modified nanoparticles for intracellular delivery of therapeutic agents and composition for making same |
10/21/2014 | US8865215 Matrix for tissue repair |
10/21/2014 | US8865214 Bioactive gypsum starch composition |
10/21/2014 | US8865213 Modified release pharmaceutical compositions |
10/21/2014 | US8865212 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same |
10/21/2014 | US8865211 Bioadhesive drug formulations for oral transmucosal delivery |
10/21/2014 | US8865210 Stable dosage formulations of imidazolylalkyl-pyridines |
10/21/2014 | US8865209 Combined sublingual and gastro-intestinal delivery method of a liquid medication in a single volume limited dose |
10/21/2014 | US8865208 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
10/21/2014 | US8865207 Compositions and methods for delivering active agents in transdermal drug delivery systems |
10/21/2014 | US8865206 Surface modified multilayered nanostructures for dermal delivery |
10/21/2014 | US8865205 Bioswellable sutures |
10/21/2014 | US8865204 Manufacture of lozenge product with radiofrequency |
10/21/2014 | US8865203 Pharmacokinetics of S-adenosylmethionine formulations |
10/21/2014 | US8865202 Water soluble film for oral administration with instant wettability |
10/21/2014 | US8865201 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders |
10/21/2014 | US8865200 Sustained release compositions containing progesterone receptor modulators |
10/21/2014 | US8865198 Method for treating a periodontal disease |
10/21/2014 | US8865190 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
10/21/2014 | US8865188 Methods and compositions for controlling assembly of viral proteins |
10/21/2014 | US8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
10/21/2014 | US8865178 Compositions and methods for wound healing |
10/21/2014 | US8865161 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease |
10/21/2014 | US8865156 Compositions and methods for the maintenance of oral health |
10/21/2014 | US8865150 pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules |
10/21/2014 | US8865148 Polyesteramide platform for site specific drug delivery |
10/21/2014 | US8865143 Reversely thermo-reversible hydrogel compositions |
10/21/2014 | US8865139 Topical tetracycline compositions |
10/21/2014 | US8865134 Chewing gum |
10/21/2014 | US8865133 Bi-Layer Pressed Powders Oral Adhering Tablet with Acacia gum adhesive |
10/21/2014 | US8865132 Compressed gas aerosol compositions |
10/21/2014 | US8865131 Preparation for use in opthalmology and retinal surgery |
10/21/2014 | US8865129 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof |
10/21/2014 | US8865127 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
10/21/2014 | US8865032 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene |
10/21/2014 | US8865021 Compositions of lipids and cationic peptides |
10/21/2014 | US8864727 Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
10/21/2014 | US8864047 Method for producing a multilayer compound on a CIP-capable coating installation and use of the multilayer compound produced by said method for transdermal application or the application in body cavities |
10/21/2014 | US8863756 Tobacco chewing gum formulation |